Cystic Fibrosis: Recent Insights into Inhaled Antibiotic Treatment and Future Perspectives
Sign Up to like & getrecommendations! Published in 2021 at "Antibiotics"
DOI: 10.3390/antibiotics10030338
Abstract: Although new inhaled antibiotics have profoundly improved respiratory diseases in cystic fibrosis (CF) patients, lung infections are still the leading cause of death. Inhaled antibiotics, i.e., colistin, tobramycin, aztreonam lysine and levofloxacin, are used as… read more here.
Keywords: cystic fibrosis; inhaled antibiotics; treatment; inhaled antibiotic ... See more keywords